B · Normal
[Swedish Nanexa’s stock price rose 150% after reaching a global licensing agreement with Novo Nordisk] On September 25, Sweden’s Nanexa’s stock price rose 150% after reaching a global licensing agreement with Novo Nordisk. Previously, Novo Nordisk and Swedish Nanexa signed a drug technology cooperation agreement worth 1.165 billion euros.
Comments